575 related articles for article (PubMed ID: 8809240)
1. Extraintestinal considerations in inflammatory bowel disease.
Levine JB; Lukawski-Trubish D
Gastroenterol Clin North Am; 1995 Sep; 24(3):633-46. PubMed ID: 8809240
[TBL] [Abstract][Full Text] [Related]
2. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects.
Papa A; Scaldaferri F; Danese S; Guglielmo S; Roberto I; Bonizzi M; Mocci G; Felice C; Ricci C; Andrisani G; Fedeli G; Gasbarrini G; Gasbarrini A
Dig Dis; 2008; 26(2):149-55. PubMed ID: 18431065
[TBL] [Abstract][Full Text] [Related]
3. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.
Caradonna L; Amati L; Magrone T; Pellegrino NM; Jirillo E; Caccavo D
J Endotoxin Res; 2000; 6(3):205-14. PubMed ID: 11052175
[TBL] [Abstract][Full Text] [Related]
4. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
[TBL] [Abstract][Full Text] [Related]
6. [Cutaneous and mucosal manifestations of inflammatory bowel diseases].
Károlyi Z; Erós N; Ujszászy L; Nagy G
Orv Hetil; 2000 Jun; 141(25):1391-5. PubMed ID: 10934882
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease. Current concepts of pathogenesis and implications for therapy.
Fiocchi C
Minerva Gastroenterol Dietol; 2002 Sep; 48(3):215-26. PubMed ID: 16491045
[TBL] [Abstract][Full Text] [Related]
8. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
9. Cytokines in inflammatory bowel disease.
Kmieć Z
Arch Immunol Ther Exp (Warsz); 1998; 46(3):143-55. PubMed ID: 9704146
[TBL] [Abstract][Full Text] [Related]
10. Extraintestinal manifestations of inflammatory bowel disease.
Urlep D; Mamula P; Baldassano R
Minerva Gastroenterol Dietol; 2005 Jun; 51(2):147-63. PubMed ID: 15990704
[TBL] [Abstract][Full Text] [Related]
11. Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia.
Spina L; Saibeni S; Battaglioli T; Peyvandi F; de Franchis R; Vecchi M
Am J Gastroenterol; 2005 Sep; 100(9):2036-41. PubMed ID: 16128949
[TBL] [Abstract][Full Text] [Related]
12. Genes, diet and inflammatory bowel disease.
Ferguson LR; Shelling AN; Browning BL; Huebner C; Petermann I
Mutat Res; 2007 Sep; 622(1-2):70-83. PubMed ID: 17628615
[TBL] [Abstract][Full Text] [Related]
13. [Inflammatory bowel disease and lung].
Ceyhan B
Tuberk Toraks; 2006; 54(3):292-8. PubMed ID: 17001550
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis and clinical approach to extraintestinal manifestations of inflammatory bowel disease.
Agrawal D; Rukkannagari S; Kethu S
Minerva Gastroenterol Dietol; 2007 Sep; 53(3):233-48. PubMed ID: 17912186
[TBL] [Abstract][Full Text] [Related]
15. [Crohn's disease: a still tourbillon of etiopathogenetic theories and therapeutic strategies. Some implications in the field of urology].
Alberti C
G Chir; 2010 Mar; 31(3):124-33. PubMed ID: 20426926
[TBL] [Abstract][Full Text] [Related]
16. Extraintestinal manifestations of inflammatory bowel disease.
Ardizzone S; Puttini PS; Cassinotti A; Porro GB
Dig Liver Dis; 2008 Jul; 40 Suppl 2():S253-9. PubMed ID: 18598997
[TBL] [Abstract][Full Text] [Related]
17. Therapy insight: Vascular complications in patients with inflammatory bowel disease.
Koutroubakis IE
Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):266-72. PubMed ID: 16265230
[TBL] [Abstract][Full Text] [Related]
18. Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?
Reuter BK; Pizarro TT
Eur J Immunol; 2004 Sep; 34(9):2347-55. PubMed ID: 15307167
[TBL] [Abstract][Full Text] [Related]
19. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review.
Apgar JT
Semin Dermatol; 1991 Sep; 10(3):138-47. PubMed ID: 1931561
[TBL] [Abstract][Full Text] [Related]
20. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management.
Larsen S; Bendtzen K; Nielsen OH
Ann Med; 2010 Mar; 42(2):97-114. PubMed ID: 20166813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]